Downregulated gene products include putative tumor suppressor genes (SCUBE2), factors previously reported as lost in aggressive bladder cancer (FOXA1, GATA3, UPK3A), and metabolizing enzymes with polymorphisms affecting cancer risk (UGT1A10, UGT1A7). The gene discussed is UGT1A10; the disease is urinary bladder carcinoma.